The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer

The role of targeted therapies in the treatment of women with breast cancer has been rapidly evolving. Trastuzumab, a monoclonal antibody against the human epidermal growth factor receptor 2 (her2), was the first her2-targeted therapy that clearly demonstrated a significant clinical benefit for wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Dent, S., Verma, Sh., Latreille, J., Rayson, D., Clemons, M., Mackey, J., Verma, Su., Lemieux, J., Provencher, L., Chia, S., Wang, B., Pritchard, K.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2009
Materias:
Practice Guideline Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722050/
https://www.ncbi.nlm.nih.gov/pubmed/19672422

Ejemplares similares

Ejemplares similares